BACKGROUND AND PURPOSE: The prevalence of antiplatelet drug resistance among
patients who undergo cerebrovascular stent placement is unknown. We aimed to assess the …

BACKGROUND AND PURPOSE: Antiplatelet drug resistance has been associated with
thromboembolic complications in patients after coronary stent placement. It has not been …

Objective The aim of this study was to analyze the correlation between thromboembolic
complications and antiplatelet drugs before and after neurointervention. Methods Blood …

Antiplatelet resistance is emerging as a significant factor in effective secondary stroke
prevention. Prevalence of aspirin and clopidogrel resistance is dependent upon laboratory …

Purpose Cerebral ischemic lesions are frequently observed after carotid artery stenting
(CAS), and anti-platelet agents are used to prevent stent thrombosis and peri-procedural …

BACKGROUND AND PURPOSE: Clopidogrel resistance is blamed for thromboembolic
complications in neurovascular stent placement. Platelet-function assays are weakly …

BACKGROUND AND PURPOSE: Clopidogrel and aspirin are antiplatelet medications used
in patients intended for endovascular stent placement. Although various studies have …

ABSTRACT BACKGROUND/OBJECTIVE Symptomatic thromboembolic events are the most
common complications associated with aneurysm coiling, and carotid and intracranial …

Purpose: The purpose of the study was to assess clopidogrel resistance and whether
“intensified” antiplatelet therapy guided by platelet inhibition tests during neuroendovascular …

Objective Limited data exist regarding the use of antiplatelet response assays during
neuroendovascular intervention. We report outcomes after carotid artery stenting (CAS) …